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ABSTRACT
Introduction
Type 2 diabetes is one of the commonest chronic 
conditions in Malta posing a major health burden as a 
result of the complications that may arise. Evaluating 
patient management and comparing them to standard 
guidelines such as those set by the International Diabetes 
Federation (IDF) is an important step in improving care.
Objective
The study aimed to assess whether the practice at the 
diabetic clinic in Mosta Health Centre is in line with 
IDF targets for glycosylated haemoglobin (HbA1c), lipid 
profile and urinary albumin/creatinine ratio (ACR).
Method
All patients who attended the diabetic clinic in November 
and December 2016 were included. For each, data was 
collected for investigations done retrospectively from 
the Information Clinical Manager system over the year 
preceding their appointment. Data collected included 
age, gender, HbA1c values, lipid profile readings and 
ACR values. Adherence to guidelines was calculated and 
significant trends were reported.
Results
The study involved 515 patients, of which 55.5% were 
males and 44.5% females. The majority were of the older 
age group (48.3% being older than 70 years). Results for 
each investigation considered are as follows:
For HbA1c, 99.2% of patients had this test taken, 
with 89.1% having a second reading and 53.2% having 
a third reading over the year preceding the appointment. 
There was a statistical difference of HbA1c levels between 
males and females. Of all HbA1c values taken in this 
study 45.7% adhered to the IDF standards.
For ACR, 55% of the total had a measurement. Of 
these, 69.6% were within normal limits. Of the 30.4% 
abnormal results, only 5.7% had the test repeated twice 
over 4 months.
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In this study 97.5% had at least a single lipid 
profile taken over the previous year. Of these, 88.4% 
had triglyceride levels <2.3 mmol/l, 28.3% had low-
density lipoprotein (LDL) levels <2 mmol/l, and 86.7% 
had high-density lipoprotein (HDL) levels >1 mmol/l. 
Similar values were obtained for the 52.2% of patients 
who had two lipid profile readings and for the 17.3% of 
patients who had three readings over the year prior to 
appointment.
Conclusion
Most investigations were done as per IDF standards 
but there is still room for improvement. Adhering to 
guidelines is important and this may be improved by 
raising awareness of these guidelines among general 
practitioners. Development of local guidelines would 
be ideal.
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INTRODUCTION
Background
Type 2 diabetes is one of the most common chronic 
conditions in Malta, with one in every eight of Maltese 
adults suffering from the condition (Cuschieri, et al., 
2016). This leads to a major public health burden as a 
result of the possible macrovascular and microvascular 
complications that may arise. These complications, which 
may be prevented by better diabetic control (O’Connor, 
et al., 2006) include heart disease, nephropathy and 
retinopathy. As emphasized by the International Diabetes 
Federation (IDF) Guidelines (IDF, 2012), cardiovascular 
disease is the major cause of morbidity and mortality in 
patients with type 2 diabetes. This further shows the 
importance of having a structured diabetic management 
clinic where the diabetic population is regularly 
monitored and followed up.
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Mosta Health Centre is one of eight health centres 
which are the core of the primary health care service 
provided by the government in Malta (Primary Health 
Care Department, 2017). The health centre is open 24 
hours a day, whilst the diabetes clinic within the health 
centre operates on weekdays between 08.00-13.00 
hours, except on Wednesdays. Patients need to be 
referred to the clinic by a doctor, and attendance is by 
appointment. The clinic is led by a nurse and a doctor. 
On the day of the appointment, the patient’s weight, 
blood pressure, haemoglucotest (HGT) and urinalysis 
are checked, and blood investigations taken prior to the 
appointment are reviewed. The patient’s diabetic control, 
general well-being, treatment and any necessary changes 
are discussed, as well as any related health issues that 
patients might be concerned about. Annual referrals 
for diabetic retinopathy and neuropathy screening as 
well as assessment of the peripheral vascular system are 
also organised. A follow-up appointment is given and 
investigations are ordered, to be taken a few weeks prior 
to the next appointment.
A number of guidelines about monitoring and targets 
in type 2 diabetes have been published by different 
organisations. These include the International Diabetes 
Federation (IDF, 2012), the National Institute for Health 
and Clinical Excellence (NICE, 2015) and the American 
Diabetes Association (ADA, 2017). For the purpose of 
this evaluation, the IDF guidelines have been used. 
Objective
Evaluating diabetes care is indeed a complex task. 
However, in line with the basic principles of chronic 
disease management, one important aspect of care is 
outcome assessment (Norris, et al., 2003).  As stated 
previously, preventing complications (microvascular & 
macrovascular) is one important outcome of care. It can 
be stated that the biochemical monitoring of important 
parameters that have been shown to be directly related 
to such complications is another important indicator of 
quality of care.
Thus, the study aimed to assess whether the 
practice at the diabetic clinic in Mosta Health Centre 
is in line with the standards set by the International 
Diabetes Federation (IDF, 2012) for the following three 
biochemical parameters:
•	 glycosylated haemoglobin (HbA1c),
•	 lipid profile and




This was a cross-sectional observational study. A data 
collection form was designed on Microsoft Excel to 
facilitate data collection. All patients who attended the 
diabetic clinic in November and December 2016 were 
included. Data was collected retrospectively by reviewing 
relevant investigations carried out, using the Information 
Clinical Manager (ICM) system, over the year preceding 
their appointment. Data collected included:
•	 Age and gender
•	 Values of HbA1c
•	 Values of ACR if available
•	 Values of total cholesterol, triglycerides, low-
density lipoprotein (LDL) and high-density 
lipoprotein (HDL)
Data analysis
Data input and analysis was carried out using Microsoft 
Excel. Adherence to the guidelines (%), with respect to 
targets and frequency of estimation, was calculated. In 
addition, any clinically significant trends were reported. 
Further analyses were conducted using Statistical Package 
for the Social Sciences (SPSS) programme version 22.
Study approval
This evaluation was approved by the Department of 
Primary Health Care and by the Data Protection officer 
of the Department. 
Standards
The standards were obtained from the IDF guideline 
Global Guideline for Type 2 Diabetes (IDF, 2012). These 
were chosen since, when compared with other guidelines, 
namely ADA (2017) and NICE (2015), they were thought 
to be more appropriate for an evaluation study. This 
guideline recommends the following:
Glycosylated haemoglobin (HbA1c): 
•	 Measure HbA1c every 2 to 6 months depending on 
level, stability of blood glucose control and changes 
in therapy.
•	 Target of HbA1c less than 7%.
 
In this evaluation, HbA1c levels were reported as DCCT-
aligned units (%) and not IFCC units (mmol/mmol) as the 
latter have only been recently introduced, and most GPs are 
more familiar with the DCCT-aligned units.
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Urinary microalbuminuria
•	 Measure urinary albumin/creatinine ratio yearly.
•	 If ACR is raised (microalbuminuria ACR > 2.5 
mg/mmol in men, > 3.5 mg/mmol in women), 
repeat ACR twice over the following 4 months. 
Microalbuminuria is confirmed if ACR is elevated 
in two out of three tests, in the absence of infection 
or overt proteinuria. If both repeat tests are not 
raised, check again annually.
Lipid profile
•	 Measure lipid profile yearly.
•	 Lipid targets are as follows:
 LDL cholesterol < 2.0 mmol/l (should be < 1.8 
mmol/l in established cardiovascular disease)
Triglyceride < 2.3 mmol/l
HDL cholesterol > 1.0 mmol/l
RESULTS 
Demographic details 
During the period of this study, between November 
and December 2016, 515 patients had a registered 
appointment at the Mosta Health Centre diabetic clinic. 
Of these, 55.5% were males and 44.5% were females. 
The majority of the patients attending were of an older 
age group, with 48.3% being older than 70 years, closely 
followed by those aged between 60 and 69 years who 
represented 38.6% of the total number of patients. These 
results are summarised in Figure 1. 
With respect to the individual biochemical parameters, 
the results were as follows.
A. HbA1c
99.2% of the total number of patients registered during 
the study period had at least one HbA1c reading over 
the previous year (mean value = 7.36% [95% CI: 7.24-
7.47]), 89.1% had a second reading (mean 7.26% [95% 
CI: 7.15-7.38]), and 53.2% of the total 515 patients 
had a third HbA1c reading (mean 7.37 [95% CI: 7.21-
7.53]). The least HbA1c value recorded was 3.2%, with 
the highest being 12.8% for all the readings.  The overall 
mode of the total HbA1c values was 6.5%.
Comparing average HbA1c levels by gender, through 
the use of t-test, shows a statistically significant difference 
between males and females (P = 0.016) when the 
first HbA1c reading is taken into consideration, with 
males having better glycaemic control. There was a 
similar gender difference for the second and third 
HbA1c readings taken; however this difference was not 
statistically significant. Percentage values for each HbA1c 
reading according to gender are shown in Figure 2. 45.7% 
of all the HbA1c values available for the patients in this 
study adhered to the IDF standards which recommend 
HbA1c levels <7%.
Figure1: Age and sex distribution of patient population
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B. Albumin creatinine ratio
55% of the total number of patients had at least a single 
ACR measurement over the previous year, with 45% 
having had no urine taken to detect microalbuminuria. 
Of the ACR readings available, 69.6% were within 
normal limits. Of the 30.4% abnormal ACR results, the 
majority had no urine taken to retest ACR (64.4%) while 
26 patients (29.9%) had one ACR test repeated after the 
abnormal result. Only 5.7% of patients with an abnormal 
ACR had the test repeated twice over the following 4 
months as recommended by IDF.
C. Lipid profile
97.5% of the total number of patients had at least a 
single lipid profile measurement over the previous year, 
52.2% had two and 17.3% had three readings. Overall, 
when taking into consideration all the patients’ lipid 
profile readings available, 86.7% had triglyceride levels 
<2.3, 30.6% had LDL levels <2 and 86.0% had HDL 
levels >1. On further analysis, when comparing the lipid 
profile results of those having at least a single, two or 
three readings, the percentage levels were very similar.
Of the 97.5% of patients who had at least one 
lipid profile reading over the previous year, 88.4% had 
triglyceride levels <2.3 (mean value = 1.46mmol/l 
[95% CI: 1.39-1.53]), 28.3% had LDL levels <2 (mean 
value = 3.04mmol/l [95% CI: 2.08-3.99]), and 86.7% 
had HDL levels >1 (mean value = 1.98mmol/l [95% 
CI: 1.02-2.95]).
Of those with two lipid profile readings over the year 
preceding the appointment, 86.2% had triglyceride levels 
<2.3 (mean value = 1.55mmol/l [95% CI: 1.44-1.66]), 
30.9% had LDL levels <2 (mean value = 2.41mmol/l 
(95% CI: 2.32-2.50]), and 87% had HDL levels >1 (mean 
value = 1.39mmol/l [95% CI:1.34 -1.44]).
Of the 17.3% of patients who had three lipid profile 
readings, 85.4% had triglyceride levels <2.3 (mean value 
= 1.66mmol/l [95% CI: 1.43-1.89]), 32.6% had LDL 
levels <2 (mean value = 5.90mmol/l [95% CI: 0.94-
12.75]), and 84.3% had HDL levels >1 (mean value = 
1.37mmol/l [95% CI: 1.28-1.47]).
A summary of the overall results, compared with IDF 
standards, can be seen in Table 1. 
DISCUSSION
Evaluation
In this evaluation, 44.5% of the study population was 
represented by females. One explanation for this may be 
that the prevalence of diabetes in Malta, as stated in the 
Report on the Performance of the Maltese Health System 
(Grech, et al., 2015), has been found to be significantly 
higher in males aged 15 years and older. On the other 
hand, the fact that the population sample was taken 
only over a one-month period might not be an accurate 
representation of the total population seen over one 
whole year.
The majority of the patients in this evaluation had at 
least one HbA1c reading over the preceding year, with 
only 0.8% having no readings. 89.1% of the patients 
had at least two HbA1c readings over a one year period, 
and therefore it can be concluded that this percentage 
adhered to the IDF recommendation that HbA1c levels 
Figure 2: Average HBA1c levels by gender of patient population
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should be checked every 2-6 months depending on 
the control. Approximately 47% of the patients had 
satisfactory HbA1c levels (less than 7%) according to 
IDF recommendations (2012). This ranks well when one 
compares satisfactory HbA1c percentages quoted in other 
audits, such as the one done at a primary health care 
centre in Oman (Ahmed and Qurashi, 2014) with 35% 
having satisfactory HbA1c levels of less than 7%, or an 
audit done at the primary health care facilities in Dubai 
(Othman, et al., 2015) where 44.1% had satisfactory 
HbA1c levels of less than 7%, or the percentage of 41% 
stated in the American National Electronic Health Record 
(Gill and Foy Yu Ling, 2006).
This study’s percentage shows an improvement 
when compared to data of a local study, which had 
shown that approximately 33% of the patients in the 
study had satisfactory HbA1c control (Cutajar, 2007). It 
should be noted however, that IDF standards at the time 
recommended HbA1c levels less than 6.5%. On further 
evaluation, 28% of the patients in this study had HbA1c 
levels less than 6.5%, as per previous standards, and this 
shows a deterioration when compared to the same study 
in 2007 which had shown that 38.2% of the patients at 
Mosta Health Centre had HbA1c within target (Cutajar, 
2007). The results also show a difference in HbA1c 
control between genders, with females having poorer 
glycaemic control when compared to males. This finding 
has been documented previously (Cambra, et al., 2016). 
Only 55% of the total number of patients had at least 
a single urine sample tested for microalbuminuria over 
the previous year, of which 30.4% were abnormal. The 
suboptimal percentage of patients being screened yearly 
for microalbuminuria is similar to studies carried out in 
other countries.  Some studies, such as those done by 
Anabtawi and Mathew (2013), and Pilson, Snow and 
Varlett (2001) quote a variable compliance rate of 14-49% 
in the USA, while a study in the Netherlands to assess 
how frequent microalbuminuria screening was carried out 
yearly over three years (2007-2009) gave similar results to 
this study with percentages ranging from 45.2% to 57.4% 
(Hellemons, et al., 2013). This shows that there is much 
room for improvement in this aspect, as IDF standards 
(2012) recommend at least a yearly ACR measurement, 
in addition to serum creatinine and eGFR - estimated 
Glomerular Filtration Rate (which were not recorded in 
this evaluation).
There may be several reasons behind these low rates 
of compliance across different areas. The study carried 
out by Pilson, Snow and Vartlett (2001) aimed to find 
out the compliance rates with guidelines in diabetic care 
and also the reasons suggested by physicians behind the 
low compliance rates that resulted. They point out that 
some physicians raised questions regarding the utility of 
carrying out ACR testing in patients with end-stage renal 
disease while other physicians expressed their concern 
that assessing for microalbuminuria in patients who 
are already on ACE (angiotensin-converting-enzyme) - 
inhibitors would be inappropriate, given the fact that 
management of microalbuminuria would remain the 
same. However, it can be argued that despite the latter 
reason being very valid, optimizing blood pressure 
control in ACR positive patients remains a priority. This 
Table 1: Compaarison with IDF standards
IDF target Achieved Not Achieved
HbA1c
7% 45.7% 54.3%
Measure every 2-6 months 89.1% 10.9%
Urinary ACR Measure yearly 55.0% 45.0%
Lipid profile
Measure yearly 97.5% 2.5%
LDL<2.0mmo1/1 30.6% 69.4%
Triglycerde<2.3mmol/l 86.7% 13.3%
HDL>1.0 mmo1/l 86.0% 14.0%
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study did not take into consideration the past history, 
drug history or blood pressure levels of patients and 
therefore we cannot give account for the above three 
factors. The guidelines do not only stress on yearly 
monitoring but also on further evaluation upon finding 
a high ACR result.
The result of this study that 64.4% of patients 
with positive ACR result had no further testing done 
is worrying. If one reviews audits abroad there is also 
a similar problem. In a study by Fifield, James and 
Ajmal-Ali (2005), 57% of patients were new cases of 
microalbuminuria and had no further monitoring. 
Chronic kidney disease is one of the major complications 
of diabetes, and is associated with an increased risk of 
morbidity and mortality (IDF, 2012). Early detection 
of developing kidney damage is useful in helping to 
minimize harm by appropriate interventions. These 
may include tighter blood pressure control, use of ACE-
inhbitors or angiotensin II receptor blockers (ARBs), and 
referral to specialist clinics, such as the Chronic Kidney 
Disease Prevention Clinic (CKDPC) within the Primary 
Health Care Department. The latter is a nurse-led clinic, 
with the primary aim of education and monitoring of 
patients with established early kidney disease to help 
prevent deterioration in their condition (Primary Health 
Care Department, 2016).
Most of the patients in this evaluation had at least 
a single lipid profile measurement, with only 2.5% not 
adhering to the IDF recommendations of a yearly lipid 
profile test. The majority of readings (86.7%) showed 
triglyceride levels less than 2.3mmol/l, however only 
30.6% had LDL levels less than 2mmol/l. Considering 
the results of Cutajar (2007), overall 10.9% of patients 
were found to have LDL values less than 2.51mmol/l. 
Of particular note is the change in IDF standards over 
the span of 10 years, with stricter control recommended 
for LDL levels as opposed to HbA1c levels. Lipid profile 
results of patients who had a single, two or three readings 
in the previous year were similar, and therefore this does 
not give much indication as to the reason why some 
patients had multiple readings taken. Of particular 
note is the fact that, of the patients with a second lipid 
profile reading, 37% had triglyceride levels > 2.3 when 
compared to 11.6% and 13% of patients with at least a 
single, and three readings respectively. 
Strengths and limitations
The sample of 515 patients used in this study, who had 
been seen at the Mosta Health centre diabetic clinic over 
a period of two months, represent approximately one 
sixth of the total number of patients seen yearly. This is 
therefore quite a good representation of the population 
of patients that are seen at the clinic. A larger evaluation 
including patients visiting diabetic clinics in other health 
centres would have yielded results that can be said to be 
more representative of the whole population.
The number of patients who did not turn up for 
their diabetic clinic appointment was not taken into 
consideration in this evaluation. This can be a reason for 
some of the missing investigations, including the small 
percentage of patients who did not have a single HbA1c 
level taken during the year preceding the appointment, 
and it can be considered to be a limitation in this study. 
The results of the albumin/creatinine ratio recorded 
were not standardised, with some of them having 
the albumin creatinine ratio, while others having 
microalbumin level in the urine. Also, the units used in 
Malta are mg/g for ACR and mg/l for microalbumin, as 
opposed to mg/mmol found in the IDF guidelines. The 
upper limit of normal for both males and females is taken 
to be 20mg/g for ACR and 20mg/l for microalbumin. In 
view of this, it was not possible to compare the results 
with each other, derive the range, mode and average of 
the values available and evaluate the results by gender 
according to IDF standards. In this study, only whether 
results were normal or abnormal was evaluated, and in 
the case of abnormal results it was checked whether the 
ACR was repeated twice over the following 4 months.
The patients’ blood pressure, body mass index, waist 
circumference and medications were not included in the 
study data, and having this information would have made 
a more thorough evaluation possible.
CONCLUSION
Recommendations
All general practitioners who assess patients with diabetes 
should be made aware and reminded (through lectures, 
seminars and other teaching opportunities) of the latest 
guidelines in the management of this very common 
chronic condition.  A chart with the most important 
recommended standards can be made available in 
the diabetic clinic, GP rooms or else as a soft copy on 
every computer, for easy access. Development of local 
guidelines about diabetes would be ideal, considering 
the high prevalence of this condition.
The diabetic clinic form available for filling in patient 
details, examination and investigation results may be 
modified to make it easier for GPs to avoid missing 
out important investigations and referrals, and to focus 
more on reaching target levels. A space should also be 
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made available to record any particular reasons why 
certain investigations may be felt to be unnecessary or 
are difficult to perform on certain patients. This will aid 
evaluation of practice in the future. Re-evaluation after 
adequate staff training may be undertaken, and a larger 
sample of patients can be studied.
Conclusion
The diabetic clinic at Mosta Health Centre helps to 
provide diabetic patients with a structured care approach. 
The aim of this study has been reached in assessing 
whether current practices at the diabetic clinic are in line 
with IDF standards. Most of the investigations are being 
done as specified by IDF standards in a good percentage 
of patients, especially when these results are compared 
to other audits done in primary health care. However 
more serious consideration should be given to improving 
diabetes control by focusing on reaching specific targets. 
Therefore, one should also aim to manage patients in 
a holistic manner, using a multidisciplinary team and 
a system which empowers patients to lead a healthy 
lifestyle and fight obesity.
